Evidence map›Paper›PMID 36785779›Full record

ArticleJournal of intensive medicine2022

Assessment of respiratory support decision and the outcome of invasive mechanical ventilation in severe COVID-19 with ARDS.

Shuhan Cai, Fangfang Zhu, Hongtao Hu, Hui Xiang, Dawei Wang, Jing Wang, Lu Li, Xiao Yang, Aihua Qin, Xin Rao and 5 more

Abstract read
In one paragraph

Article in Journal of intensive medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shuhan CaiDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Fangfang ZhuDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Hongtao HuDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Hui XiangDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Dawei WangDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Jing WangDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Lu LiDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Xiao YangDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Aihua QinDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Xin RaoDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Yun LuoDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Jianguo LiDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Kianoush B KashaniDivision of Nephrology and Hypertension, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Bo HuDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
Zhiyong PengDepartment of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coronavirus disease 2019 (COVID-19) is an ongoing pandemic. Invasive mechanical ventilation (IMV) is essential for the management of COVID-19 with acute respiratory distress syndrome (ARDS). We aimed to assess the impact of compliance with a respiratory decision support system on the outcomes of patients with COVID-19-associated ARDS who required IMV. Methods: In this retrospective, single-center, case series study, patients with COVID-19-associated ARDS who required IMV at Zhongnan Hospital of Wuhan University, China, from January 8th, 2020, to March 24th, 2020, with the final follow-up date of April 20th, 2020, were included. Demographic, clinical, laboratory, imaging, and management information were collected and analyzed. Compliance with the respiratory support decision system was documented, and its relationship with 28-day mortality was evaluated. Results: The study included 46 COVID-19-associated ARDS patients who required IMV. The median age of the 46 patients was 68.5 years, and 31 were men. The partial pressure of arterial oxygen (PaO Conclusions: For severe COVID-19-associated ARDS with IMV, following the respiratory support decision and assessing completion would improve the progress of ventilation. With a decision score of >11.5, the mortality at 28 days after ICU admission showed an obvious decrease.

Indexed as

Acute respiratory distress syndrome (ARDS)COVID-19Invasive mechanical ventilationRespiratory support decisionSevere acute respiratory coronavirus 2 (SARS-CoV-2)

Identifiers

PMID36785779
PMCPMC8810377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.